Sherwin-Williams (SHW) reported an insider equity grant. The company’s President & CEO, who is also a director, received 47,630 employee stock options on October 20, 2025 at an exercise price of $331.37 per share. These options expire on October 19, 2035 and vest in three substantially equal annual installments beginning October 20, 2026, pursuant to the 2025 Equity and Incentive Compensation Plan. No open-market stock sales or purchases were reported.
Sherwin-Williams (SHW) reported an insider equity award on Form 4. The company granted its SVP–Finance & CFO an employee stock option for 16,920 shares at an exercise price of $331.37 per share on October 20, 2025, under the 2025 Equity and Incentive Compensation Plan.
The options vest annually in three substantially equal installments commencing October 20, 2026, and carry an expiration date of October 19, 2035. Following the reported transaction, the reporting person holds 16,920 derivative securities directly.
Sherwin-Williams (SHW) disclosed a Form 4 showing its President, Global Architectural, received an employee stock option grant for 10,860 shares at an exercise price of $331.37 on October 20, 2025.
The options expire on October 19, 2035 and vest annually in three substantially equal installments starting October 20, 2026. After the grant, 10,860 derivative securities are listed as directly owned.
Sherwin-Williams (SHW) reported an equity compensation grant to an officer. On October 20, 2025, the SVP - CLO and Secretary was awarded 7,940 employee stock options with an exercise price of $331.37 per share. The options were granted under the company’s 2025 Equity and Incentive Compensation Plan and carry no purchase price at grant.
The options vest annually in three substantially equal installments commencing October 20, 2026, and expire on October 19, 2035. Ownership is listed as Direct.
Sherwin-Williams (SHW) disclosed an officer stock option grant in a Form 4. The filing reports an award of 6,270 employee stock options on October 20, 2025 at an exercise price of $331.37 per share. The officer is identified as Pres. & GM, Glob. Supply Chain.
The options were granted under the 2025 Equity and Incentive Compensation Plan and vest annually in three substantially equal installments commencing October 20, 2026. The options expire on October 19, 2035. Following the reported transaction, 6,270 derivative securities were beneficially owned, with direct ownership indicated.
Sherwin-Williams (SHW) reported an insider equity grant: its SVP–CHRO received 6,060 employee stock options with an exercise price of $331.37 per share on October 20, 2025, under the 2025 Equity and Incentive Compensation Plan.
The options vest in three substantially equal annual installments starting October 20, 2026, and expire on October 19, 2035. This is a standard compensation award that sets the right to buy common stock at a fixed price over time as service-based vesting conditions are met.
Sherwin-Williams (SHW) disclosed a routine insider equity grant. The company’s President, Consumer Brands Group, reported the award of 4,595 employee stock options on October 20, 2025 with an exercise price of $331.37 and expiration on October 19, 2035.
The options vest in three substantially equal annual installments beginning October 20, 2026, under the 2025 Equity and Incentive Compensation Plan. Following this grant, the reporting person beneficially owns 4,595 derivative securities, held directly. This filing reflects standard compensation rather than an open‑market transaction.
Sherwin-Williams (SHW) reported an insider equity award. The company’s SVP – Corp Strategy & Devel. received an employee stock option grant for 3,340 shares at an exercise price of $331.37 on 10/20/2025, recorded as an acquisition. The options expire on 10/19/2035 and were reported as Direct ownership.
The award vests annually in three substantially equal installments commencing 10/20/2026, pursuant to the 2025 Equity and Incentive Compensation Plan. The derivative security price was reported as $0.
Sherwin-Williams (SHW) reported an insider equity award on Form 4. An officer (SVP – IR & Corp. Comm.) was granted an employee stock option to purchase 2,510 shares at an exercise price of $331.37 on October 20, 2025. The options expire on October 19, 2035 and vest annually in three substantially equal installments commencing October 20, 2026, subject to vesting conditions. Following the grant, 2,510 derivative securities were beneficially owned directly.
Sherwin-Williams (SHW) reported an insider equity grant for its SVP – Enterprise Finance & CAO. A Form 4 discloses the award of 2,300 employee stock options at an exercise price of $331.37 per share on 10/20/2025.
The options were granted under the 2025 Equity and Incentive Compensation Plan and vest annually in three substantially equal installments beginning 10/20/2026, subject to vesting conditions. The options expire on 10/19/2035. Following the transaction, the reporting person beneficially owned 2,300 derivative securities, held directly.